Hao, Yixuan
(2022)
Virus CKB 2.0: Viral-associated disease-specific chemogenomics knowledgebase.
Master's Thesis, University of Pittsburgh.
(Unpublished)
Abstract
Given that mutations in viruses always occur during evolution, the doctor calls for a flu vaccine every year. Vaccines obtained from diseased strains have a protective effect of 40%-60%. However, if the diseased strain is mutated, the vaccine will lose its effect. Therefore, it is very necessary to track the data and structure of different viruses for research purposes. Viruses have different domains that are related to the invasion or replication of the virus, so drugs targeting these different domains can provide therapeutic potential for the treatment of diseases caused by these viruses. To facilitate the research of viral infection disease, we updated our Virus-CKB 1.0 to 2.0 by adding structure information of another ten viruses and integrating new functions (e.g., protein-protein docking). To date, Virus-CKB 2.0 archived 65 antiviral drugs in the market, 178 viral-related targets with 291 available 3D crystal or cryo-EM structures, and 3766 chemical agents reported for these target proteins. Moreover, Virus-CKB 2.0 is implemented with web applications for the prediction of the relevant protein targets and analysis and visualization of the outputs, including Molecular Complex Characterizing System (MCCS) protocol, HTDocking, TargetHunter, blood-brain barrier (BBB) predictor, Spider Plot, Protein-Protein docking, etc. The Virus-CKB 2.0 server is accessible at https://www.cbligand.org/g/virus-ckb. By using the established chemogenomics tools and algorithms and newly developed tools, we can screen FDA-approved drugs and chemical compounds that may bind to these proteins involved in viral-associated diseases regulation. If the virus strain is mutated and the vaccine loses its effect, we can also screen out drugs that can be used to treat the mutated virus in a short time. For some FDA-approved drugs, we can also perform drug repurposing through Virus-CKB 2.0.
Share
| Citation/Export: |
|
| Social Networking: |
|
Details
| Item Type: |
University of Pittsburgh ETD
|
| Status: |
Unpublished |
| Creators/Authors: |
|
| ETD Committee: |
|
| Date: |
6 April 2022 |
| Date Type: |
Publication |
| Defense Date: |
30 March 2022 |
| Approval Date: |
6 April 2022 |
| Submission Date: |
4 April 2022 |
| Access Restriction: |
2 year -- Restrict access to University of Pittsburgh for a period of 2 years. |
| Number of Pages: |
73 |
| Institution: |
University of Pittsburgh |
| Schools and Programs: |
School of Pharmacy > Pharmaceutical Sciences |
| Degree: |
MS - Master of Science |
| Thesis Type: |
Master's Thesis |
| Refereed: |
Yes |
| Uncontrolled Keywords: |
virus knowledgebase, dengue virus, online drug discovery, drug repurposing |
| Date Deposited: |
06 Apr 2022 13:46 |
| Last Modified: |
06 Apr 2022 13:46 |
| URI: |
http://d-scholarship.pitt.edu/id/eprint/42477 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Actions (login required)
 |
View Item |
![[img]](http://d-scholarship.pitt.edu/style/images/fileicons/application_pdf.png)
![[feed]](/images/feed-icon-32x32.png){kind=icon}